Alumni Profile: Edward Grant (MPH, Biostatistics '13)
Edward Grant received his Master of Public Health degree in 2013 with a concentration in biostatistics. Originally from Buffalo, New York, Edward earned his Bachelor of Science degree in Mathematical Biology from the University of Michigan. Edward currently serves as the assistant director of biostatistics for DP Clinical Inc.
What I liked about getting my MPH at Maryland is that it was great having access to the resources of a large university but with the personal elements of a small program.
What is your professional focus?
Statistical analysis for pharmaceutical drug development compliant with the FDA, clinical trial design, managing a biostatistics and programming team
What made your experience unique?
The experience with my advisor was all I could have asked for out of the master’s program. A lot of people get a degree, but there isn’t much practical hands-on experience. My work used cutting edge techniques like developing R packages for high dimensional data analysis and applying them to real life data collected by the research team in the SPH. I published multiple papers and won an award for a research poster, which was helpful to my career. It was very intellectually challenging beyond just the papers and tests.
I also got really good experiences at two internships, including at the CDC National Center for Health Statistics in the Office of Research and Methodology and at the Uniformed Services University of the Health Sciences, working in their Division of Epidemiology and Biostatistics.
What stands out about public health at UMD?
It was helpful to have such easy access to the faculty, and my cohort was small so we took the same classes together. It was a great experience socially — we went to happy hours together outside of class and remained friends after graduation.
What gets you up in the morning?
Public health has the potential to change people’s lives for the better. My company focuses on drug development for rare diseases and serving a need that is not being met by larger pharmaceutical companies. Contributing to something that can save lives and improve quality of life is what gets me up in the morning.